Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight loss, Ozempic and Wegovy
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
Not just for weight loss: Wegovy may help curb alcohol addiction
The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Ozempic Could Help Curb Alcoholism
The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain to suppress the urge to drink,
Ozempic and Wegovy may be beneficial in fighting alcohol addiction: Study
The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people in Sweden who had alcohol use disorder and Type 2 diabetes.
Ozempic Appears Effective Against Alcohol Addiction
Ozempic, a diabetes drug that has become a popular drug for weight loss, has another use that could help tens of millions of Americans, researchers say. In a study published in the journal JAMA Psychiatry,
New Scientist
29m
Weight-loss medications may also ease chronic pain
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
8h
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
49m
on MSN
Teens Are Being Prescribed Wegovy and GLP-1s at Record Rates. Should Parents Be Worried?
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
KVIA
8h
Wegovy diet plan: What foods to eat and avoid while taking semaglutide
Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...
2d
on MSN
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
Healthline
2d
Ozempic and Wegovy May Provide Strong Relief from Osteoarthritis Knee Pain
Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.
The Sun
3d
Weight loss jabs like Ozempic and Wegovy could be ‘game-changers’ in tackling common cancer, say doctors
FAT jabs such as Ozempic and
Wegovy
could be “game changers” in tackling bowel cancer within five years, researchers have claimed Evidence has already shown that injections of the
weight
-
loss
...
1d
on MSN
Amgen dismisses bone density concerns related to its weight-loss drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozempic
Novo Nordisk
Mounjaro
CagriSema
Feedback